NLS Pharmaceutics Competitors and Similar CompaniesClear all
NLS Pharmaceutics's competitors and similar companies include Supernus Pharmaceuticals and Alector.
 NLS Pharmaceutics NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | |
Founding Date | Founding Date 2019 | Founding Date 2005 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Stans, CH HQ | Locations Rockville, US HQ | Locations San Francisco, US HQ |
Employees | Employees 6 | Employees 6527% increase | Employees 2382% decrease |
Valuation ($) | Valuation ($) 10.2 m | Valuation ($) 1.9 b | Valuation ($) 495.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $719m (FY, 2025) | Revenue (est.) $21m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $74.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $2.5m (FY, 2024) | Gross profit $644.4m (FY, 2025) | Gross profit N/A |
Net income | Net income ($2m) (FY, 2024) | Net income ($38.6m) (FY, 2025) | Net income ($142.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 69.5m | Total funding raised $ 194.5m |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View company